ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

16.42
Delayed Data
As of Aug 05
 +0.80 / +5.12%
Today’s Change
12.24
Today|||52-Week Range
28.06
-29.65%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues61.0K17.3M124.9M223.8M
 
 
 
 
 
Cost of Goods Sold--1.2M6.4M9.4M
 
 
 
 
Depreciation And Amortization647.0K1.8M2.7M3.0M
 
 
 
 
 
 
Operating ExpensesGross Income--14.3M115.8M211.4M
 
 
 
 
General Expenses161.5M285.7M404.3M458.9M
 
 
 
 
 
Other Operating Expenses2.5M1.3M4.0M0.00
 
 
 
 
Research And Development73.9M99.3M149.2M187.2M
 
 
 
 
 
Total Operating Expenses164.7M290.1M417.3M471.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-164.6M-272.8M-292.4M-247.4M
 
 
 
 
 
Other Expenses0.000.000.00-1.8M
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-164.1M-270.1M-288.3M-243.9M
 
 
 
 
 
Income Taxes-330.0K-1.3M-1.1M-1.3M
 
 
 
 
 
Net Income-164.4M-271.4M-289.4M-245.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS100.6M115.9M122.6M126.6M
 
 
 
 
 
Shares To Calculate EPS Diluted100.6M115.9M122.6M126.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.63-$2.34-$2.36-$1.94
 
 
 
 
 
EPS Diluted-$1.63-$2.34-$2.36-$1.94